Osteogenesis by recombinant human bone morphogenetic protein-2 at skeletal sites

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Oral and Maxillofacial Surgery

Background:

• Bone defects in the mandible present significant clinical challenges.
• Effective bone regeneration strategies are crucial for reconstructive surgery.
• Investigating novel combinations of growth factors and biomaterials is essential.

Purpose of the Study:

• To evaluate osteogenesis in mandibular defects using varying dosages of recombinant human bone morphogenetic protein-2 (rhBMP-2).
• To assess the efficacy of atelopeptide Type I collagen as a carrier and porous hydroxyapatite as a scaffold for rhBMP-2.
• To determine the optimal combination for promoting mandibular bone healing.

Main Methods:

• Four experimental groups were established: varying rhBMP-2 dosages (2, 10, 50 µg) with atelopeptide Type I collagen and porous hydroxyapatite, and a control group (collagen and hydroxyapatite only).
• Materials were implanted into standardized mandibular bone defects (7 mm diameter, 2 mm deep).
• Osteogenesis was assessed after three weeks via alkaline phosphatase activity and histological examination.

Main Results:

• Significant differences in histological and biochemical findings were observed across all groups.
• Osteogenesis increased proportionally with the dosage of rhBMP-2, as evidenced by elevated alkaline phosphatase activity and improved histological bone formation.
• The combination of rhBMP-2, atelopeptide Type I collagen, and porous hydroxyapatite demonstrated dose-dependent osteogenic potential.

Conclusions:

• Atelopeptide Type I collagen serves as an effective carrier for rhBMP-2 in promoting mandibular osteogenesis.
• Porous hydroxyapatite is a suitable scaffold material, maintaining structural integrity for clinical applications.
• rhBMP-2, when combined with appropriate carriers and scaffolds, shows significant promise for enhancing bone regeneration in the mandible.